INO
Inovio Pharmaceuticals Inc
Price:  
6.28 
USD
Volume:  
292,384.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INO WACC - Weighted Average Cost of Capital

The WACC of Inovio Pharmaceuticals Inc (INO) is 7.4%.

The Cost of Equity of Inovio Pharmaceuticals Inc (INO) is 7.65%.
The Cost of Debt of Inovio Pharmaceuticals Inc (INO) is 6.65%.

Range Selected
Cost of equity 6.10% - 9.20% 7.65%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 6.30% - 7.00% 6.65%
WACC 6.0% - 8.9% 7.4%
WACC

INO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.5 0.77
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 9.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.09 0.09
Cost of debt 6.30% 7.00%
After-tax WACC 6.0% 8.9%
Selected WACC 7.4%